Search Results - "Annovazzi, A"

Refine Results
  1. 1

    Effects of inclusions on the performance of a solid rocket motor by Ponti, F., Mini, S., Fadigati, L., Ravaglioli, V., Annovazzi, A., Garreffa, V.

    Published in Acta astronautica (01-12-2021)
    “…Some of the most common defects that can be generated during the production of solid propellant are voids and porosity, usually associated with the casting…”
    Get full text
    Journal Article
  2. 2

    A novel procedure to determine the effects of debonding on case exposure of solid rocket motors by Mini, S., Ponti, F., Annovazzi, A., Ravaglioli, V., Moro, D.

    Published in Acta astronautica (01-01-2022)
    “…Solid rocket motors are complex systems which need to withstand extreme physical conditions in terms of temperature, pressure, and high-density energy release…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Delivery of selective internal radiation therapy complicated by variant hepatic vascular anatomy by Paladini, A, Vallati, G E, Beomonte Zobel, D, Paladini, L, Annovazzi, A, Sciuto, R, Cappelli, F, Borzelli, A, Pane, F, Negroni, D, Cernigliaro, M, Galbiati, A, Del Sette, B, Spinetta, M, Guzzardi, G, Carriero, A, Pizzi, G

    Published in Radiology case reports (01-06-2019)
    “…"Difficult vascular anatomy" is a challenge for Interventional Radiologists especially in liver directed therapies such as trans arterial radio embolization…”
    Get full text
    Journal Article
  5. 5

    Peptide radiopharmaceuticals for diagnosis and therapy by Signore, A, Annovazzi, A, Chianelli, M, Corsetti, F, Van de Wiele, C, Watherhouse, R N

    Published in European journal of nuclear medicine (01-10-2001)
    “…Radiolabelled peptides are an emerging class of radiopharmaceuticals that share chemical and biological properties. From the chemical point of view they have a…”
    Get full text
    Journal Article
  6. 6

    Receptor targeting agents for imaging inflammation/infection: where are we now? by Signore, A, Chianelli, M, D'Alessandria, C, Annovazzi, A

    “…Over the past 20 years, radiopharmaceutical research has brought to market a wide variety of drugs that aid in the management of infection and inflammation…”
    Get full text
    Journal Article
  7. 7
  8. 8

    New radiopharmaceuticals for imaging rheumatoid arthritis by Chianelli, M, D'Alessandria, C, Conti, F, Priori, R, Valesini, G, Annovazzi, A, Signore, A

    “…Rheumatoid arthritis (RA) is an incapacitating chronic inflammatory disease of the joints that, because of frequent relapses, requires life-long treatment. In…”
    Get full text
    Journal Article
  9. 9

    THE DEVELOPING ROLE OF CYTOKINES FOR IMAGING INFLAMMATION AND INFECTION by Signore, A, Procaccini, E, Annovazzi, A, Chianelli, M, van der Laken, C, Mire-Sluis, A

    Published in Cytokine (01-10-2000)
    “…The diagnosis of inflammatory processes is an important goal in medicine. In some cases the diagnosis is easy, based on the clinical history and the physical…”
    Get full text
    Book Review Journal Article
  10. 10
  11. 11

    1261PComparison 18F-FDG-PET/CT criteria for prediction of therapy response and clinical outcome in patients with metastatic melanoma treated with ipilimumab and PD-1 inhibitors by Vari, S, Annovazzi, A, Giannarelli, D, Pasqualoni, R, Sciuto, R, Carpano, S, Ferraresi, V, Cognetti, F

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background Immune checkpoint inhibitors (ICIs) acting against CTLA-4 and PD-1 represent a strenght therapy in patients (pts) with metastatic melanoma…”
    Get full text
    Journal Article
  12. 12

    1261P - Comparison 18F-FDG-PET/CT criteria for prediction of therapy response and clinical outcome in patients with metastatic melanoma treated with ipilimumab and PD-1 inhibitors by Vari, S., Annovazzi, A., Giannarelli, D., Pasqualoni, R., Sciuto, R., Carpano, S., Ferraresi, V., Cognetti, F.

    Published in Annals of oncology (01-10-2019)
    “…Immune checkpoint inhibitors (ICIs) acting against CTLA-4 and PD-1 represent a strenght therapy in patients (pts) with metastatic melanoma (MM). Antineoplastic…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice by Signore, A., Annovazzi, A., Giacalone, P., Beales, P. E., Valorani, M. G., Vestri, A. R., Ruberti, G., Manfrini, S., Pozzilli, P., Bulfone-Paus, S.

    Published in Diabetes/metabolism research and reviews (01-11-2003)
    “…Background It has been recently demonstrated that apoptosis is involved in beta‐cell destruction in the NOD mouse model of diabetes. The aim of the present…”
    Get full text
    Journal Article
  17. 17
  18. 18

    CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice by SIGNORE, A, ANNOVAZZI, A, PROCACCINI, E, BEALES, P. E, SPENCER, J, TESTI, R, RUBERTI, G

    Published in Diabetologia (01-12-1997)
    “…The non-obese diabetic (NOD) mouse is widely used to study the pathogenesis of insulin-dependent diabetes mellitus. However, the mechanisms responsible for…”
    Get full text
    Journal Article
  19. 19
  20. 20